Microbiología: Género Staphylococcus

Taxonomy and General Characteristics of Micrococcaceae and Staphylococcus

  • Family Micrococcaceae Taxonomy:

    • Gram-positive, catalase-positive cocci.
    • Includes the following genera:
      • Staphylococcus
      • Micrococcus
      • Kocuria
      • Kytococcus
      • Alloiococcus (specifically Alloiococcus otitidis)
  • General Characteristics of the Genus Staphylococcus:

    • Morphology and Staining: Gram-positive cocci arranged predominantly in grape-like clusters (racimos).
    • Metabolic Characteristics: Catalase-positive (++), facultative anaerobes (anaerobios facultativos).
    • Motility and Endospores: Non-motile (inmóviles), do not form endospores (no forman esporas).
    • Habitat: Commensal members of the normal flora (FN) colonizing human skin and mucous membranes.

Gram stain of Staphylococcus showing Gram-positive cocci in clusters

  • Primary Classification of Staphylococci:
    • Coagulase-Positive Staphylococci:
      • Staphylococcus aureus
    • Coagulase-Negative Staphylococci (CoNS):
      • Staphylococcus epidermidis
      • Staphylococcus saprophyticus
      • Staphylococcus capitis
      • Staphylococcus haemolyticus
      • Additional opportunistic species

Coagulase test showing positive plasma clot formation vs negative fluid

Colonization and Disease Profiles of Human Staphylococcus Species

  • Species Colonization and Disease Spectrum:
    • Staphylococcus aureus: Colonization is common (Común); Disease is common (Común).
    • Staphylococcus epidermidis: Colonization is common (Común); Disease is common (Común).
    • Staphylococcus saprophyticus: Colonization is common (Común); Disease is common (Común).
    • Staphylococcus haemolyticus: Colonization is common (Común); Disease is common (Común).
    • Staphylococcus lugdunensis: Colonization is common (Común); Disease is common (Común).
    • Staphylococcus capitis: Colonization is common (Común); Disease is infrequent (Infrecuente).
    • Staphylococcus saccharolyticus: Colonization is common (Común); Disease is rare (Rara).
    • Staphylococcus warneri: Colonization is common (Común); Disease is rare (Rara).
    • Staphylococcus hominis: Colonization is common (Común); Disease is rare (Rara).
    • Staphylococcus auricularis: Colonization is common (Común); Disease is rare (Rara).
    • Staphylococcus cohnii: Colonization is common (Común); Disease is rare (Rara).
    • Staphylococcus xylosus: Colonization is infrequent (Infrecuente); Disease is rare (Rara).
    • Staphylococcus simulans: Colonization is infrequent (Infrecuente); Disease is rare (Rara).
    • Staphylococcus caprae: Colonization is infrequent (Infrecuente); Disease is rare (Rara).
    • Staphylococcus pasteuri: Colonization is infrequent (Infrecuente); Disease is rare (Rara).
    • Staphylococcus schleiferi: Colonization is rare (Rara); Disease is rare (Rara).

Cell Wall Structure and Virulence Factors of Staphylococcus aureus

  • Structural Components of the Cell Wall:
    • Polysaccharide Capsule (Cápsula polisacarídica / Capa de limo): Outer polysaccharide layer that inhibits phagocytosis by host immune cells.
    • Peptidoglycan Layer (Capa de peptidoglicanos): Provides structural rigidity, osmotic stability, and endotoxin-like pyrogenic activity.
    • Teichoic Acid (Ácido teicoico / Polisacárido A / Ribitol Teichoic Acid): Bound to peptidoglycan; mediates bacterial adherence to mucosal and cutaneous surface cells.
    • Cytoplasmic Membrane (Membrana citoplasmática): Lipid bilayer acting as an osmotic barrier.
    • Bound Coagulase / Clumping Factor (Coagulasa ligada / Factor de agrupamiento): Surface protein that directly converts fibrinogen into fibrin, facilitating bacterial cell clumping.

Cell wall structure of Staphylococcus aureus

  • Immune Evasion via Protein A:
    • Protein A Surface Expression: Surface protein anchored to the peptidoglycan cell wall of Staphylococcus aureus.
    • Mechanism: Binds specifically to the Fc portion (crystallizable fragment) of IgG antibodies.
    • Functional Consequence: Prevents the Fc portion of IgG from binding to Fc receptors on host phagocytes (neutrophils and macrophages).
    • Contrast with Non-Protein A Species: In species lacking Protein A (such as Staphylococcus epidermidis), IgG antibodies bind surface antigens via their Fab regions, leaving the Fc region accessible to phagocyte Fc receptors and triggering phagocytosis. In S. aureus, antibody orientation is flipped, preventing opsonic recognition and allowing bacterial survival and tissue invasion.

Mechanism of Protein A evasion of phagocytosis in Staphylococcus aureus

Enzymatic Virulence Factors of Staphylococcus

  • Coagulase (Coagulasa):

    • Promotes the formation of a protective fibrin coat around staphylococcal lesions and abscesses.
    • Localizes the site of infection and shields encapsulated bacteria from host phagocytic clearance.
  • Catalase (Catalasa):

    • Produced by all Staphylococcus species.
    • Protects the organism against metabolic hydrogen peroxide accumulation and oxidative killing within phagolysosomes post-phagocytosis.
    • Catalyzes the enzymatic breakdown:         2H2O2→Catalase2H2O+O22H_2O_2 \xrightarrow{\text{Catalase}} 2H_2O + O_2
    • Serves as a fundamental biochemical test differentiating staphylococci (catalase-positive) from streptococci (catalase-negative).
  • Hyaluronidase (Hialuronidasa):

    • Hydrolyzes hyaluronic acid and acidic mucopolysaccharides found within the extracellular acellular matrix of connective tissue.
    • Facilitates tissue destruction and bacterial dissemination throughout tissue planes.
    • Produced by more than 90%90\% of Staphylococcus aureus strains.
  • Fibrinolysin / Staphylokinase (Fibrinolisina / Estafilocinasa):

    • Dissolves preformed fibrin clots, aiding in bacterial release and deep tissue penetration.
    • Produced by virtually all strains of S. aureus.
    • Staphylokinase is structurally and functionally distinct from streptococcal fibrinolysins.
  • Lipases (Lipasas):

    • Hydrolyze ester bonds in host cell lipophilic compounds and surface lipids.
    • Essential for staphylococcal survival, colonization, and invasion in cutaneous and highly sebaceous body regions.
    • Produced by 100%100\% of S. aureus isolates and over 30%30\% of coagulase-negative staphylococcal species.
  • Nuclease (Nucleasa):

    • Degrades extracellular host nucleic acids (DNA/RNA).
    • Serves as a diagnostic biomarker for S. aureus, although occasionally produced by other staphylococcal species.
  • Penicillinase / β\beta-Lactamase (Penicilinasa):

    • Hydrolyzes the β\beta-lactam ring of penicillin antibiotics, conferring drug resistance.
    • In 1941, over 90%90\% of clinical S. aureus isolates were penicillin-sensitive.
    • Rapid widespread acquisition of resistance occurred through horizontal gene transfer of transmissible plasmids carrying the β\beta-lactamase gene.

Toxins Produced by Staphylococcus aureus

  • Cytotoxins (Membrane-Damaging Toxins):

    • α\alpha-Toxin (Toxina α\alpha):
      • Alters vascular smooth muscle tone.
      • Cytotoxic to red blood cells (erythrocytes), white blood cells (leukocytes), hepatocytes, and platelets.
      • Forms transmembrane pores measuring 1–2 nm1\text{--}2\,\text{nm} in diameter.
      • Disrupts cellular ion gradients causing efflux of K+K^+ and massive influx of Na+Na^+ and Ca2+Ca^{2+}, leading to osmotic cellular swelling and rapid lytic destruction.
    • β\beta-Toxin (Toxina β\beta / Sphingomyelinase C):
      • Enzymatic specificity for membrane sphingomyelin and lysophosphatidylcholine.
      • Toxic to erythrocytes, fibroblasts, leukocytes, and macrophages.
      • Catalyzes the hydrolysis of membrane phospholipids; target cell lysis is directly proportional to the surface concentration of exposed sphingomyelin.
    • δ\delta-Toxin (Toxina δ\delta):
      • Acts as a surfactant or detergent-like peptide that non-specifically disrupts cell membrane integrity.
    • γ\gamma-Toxin and Panton-Valentine Leukocidin (PVL):
      • Bicomponent toxin system composed of six possible protein combinations: three S proteins (HlgA [hemolysin γ\gamma A], HlgC, LukS-PV) and two F proteins (HlgB, LukF-PV).
      • Capable of lysing human neutrophils and macrophages.
      • Highest hemolytic activity is observed with combinations HlgA/HlgB, HlgC/HlgB, and HlgA/LukF-PV.
      • Panton-Valentine Leukocidin (LukS-PV/LukF-PV) is exclusively leukotoxic.
      • Cellular lysis occurs via cation-permeable pore creation, inducing osmotic instability.
  • Exfoliative Toxins (Toxinas Exfoliativas - ETA and ETB):

    • Primary etiological agents mediating Staphylococcal Scalded Skin Syndrome (SSSS / SPEE).
    • Composed of two distinct isoforms: ETA (heat-stable) and ETB (heat-labile).
    • Function as serine proteases that specifically cleave desmoglein-1 in desmosomes (intercellular attachment bridges) located within the stratum granulosum layer of the epidermis.
  • Enterotoxins (Enterotoxins A--E, G--I):

    • Comprise eight distinct antigenic types (A, B, C, D, E, G, H, I) and three sub-variants of enterotoxin C.
    • Demonstrate extreme thermal stability, resisting inactivation at 100 ∘C100\,^\circ\text{C} for 30 min30\,\text{min}.
    • Resistant to proteolytic cleavage by gastric pepsin and jejunal digestive enzymes.
    • Act as superantigens: bind directly to MHC class II molecules and T-cell receptors (TCR) outside the peptide-binding groove, stimulating non-specific polyclonal T-lymphocyte proliferation and systemic cytokine storm.
    • Histopathological changes in the gastrointestinal tract include marked neutrophil infiltration into the mucosal epithelium and underlying lamina propria of the stomach and jejunum, accompanied by loss of jejunal brush border microvilli.
    • Emesis (vomiting) is triggered by enterotoxin stimulation of local mast cells to release inflammatory mediators that stimulate the central nervous system emetic center via the vagus nerve.
  • Toxic Shock Syndrome Toxin-1 (TSST-1):

    • Prototypical superantigen responsible for staphylococcal toxic shock syndrome.
    • Induces systemic vascular collapse, capillary leak, and multiorgan dysfunctions.

Pathogenesis and Clinical Syndromes of Staphylococcus aureus

  • Pathogenic Determinants:

    • Microbial Factors: Polysaccharide capsule, Protein A, teichoic acid cell wall components, coagulase, extracellular enzymes (hyaluronidase, lipases, nucleases), cytotoxins, exfoliative toxins, enterotoxins, and TSST-1.
    • Host Predisposing Factors: Traumatic tissue injury, surgical procedures, indwelling devices, underlying chronic conditions (diabetes mellitus, neoplastic disorders, chronic alcoholism/enolism), and ingestion of toxin-contaminated food products.
  • Suppurative (Invasive) Infections:

    • Impétigo (Impetigo): Superficial vesicular skin lesion progressing to honey-colored (meliceric) crusted erosions, commonly affecting the face and nostrils of children.
    • Foliculitis, Forunculosis (Furuncles), and Ántrax (Carbuncle): Suppurative hair follicle infections. Furuncles are painful, raised nodules containing purulent drainage; carbuncles represent deep, coalesced furuncles extending into subcutaneous tissue with systemic chills and fever.
    • Celulitis (Cellulitis): Spreading bacterial infection involving the deep dermis and subcutaneous soft tissues.
    • Paroniquia: Suppurative infection surrounding the nail bed.
    • Mastitis: Infection of lactating breast tissue, often introduced via nipple fissures during breastfeeding.
    • Wound Infections (Infecciones de Heridas): Postoperative surgical site infections, traumatic wound suppuration, and intravascular catheter-site entry infections.
    • Sepsis and Endocarditis: Hematogenous dissemination causing acute bacterial endocarditis, valvular destruction, and septic emboli.
    • Osteoarticular Infections: Staphylococcus aureus is responsible for greater than 90%90\% of acute osteomyelitis cases in pediatric populations.
    • Neumonía: Necrotizing pulmonary infection, frequently following viral influenza outbreaks.
  • Toxin-Mediated Clinical Syndromes:

    • Staphylococcal Food Poisoning (Intoxicación Alimentaria Estafilocócica):
      • Bacterial Multiplication Parameters: S. aureus multiplies exponentially across temperatures ranging from 6.7 ∘C6.7\,^\circ\text{C} to 45.5 ∘C45.5\,^\circ\text{C}. Enterotoxins are synthesized and secreted into foodstuffs during exponential growth.
      • Implicated Foods: Processed meats (ham, bacon), dairy products (cheeses), cream-filled pastries, mayonnaise-based salads, and inadequately refrigerated cooked dishes.
      • Clinical Presentation: Rapid, sudden onset of severe nausea, violent vomiting, abdominal cramps, and diarrhea developing 2–8 hours2\text{--}8\,\text{hours} post-ingestion of preformed toxin.
    • Síndrome de la Piel Escaldada Estafilocócica (SSSS / SPEE):
      • Mediated by exfoliative toxins ETA and ETB.
      • Characterized by widespread cutaneous erythema followed by diffuse, painless blistering and superficial desquamation of the skin, predominantly affecting neonates and young children.
    • Impétigo Bulloso (Bullous Impetigo): Localized form of SSSS presenting with intraepidermal bullae containing viable bacteria.
    • Síndrome del Shock Tóxico Estafilocócico (Staphylococcal Toxic Shock Syndrome - TSS):
      • Etiological Agent: TSST-1 superantigen (or enterotoxins B/C).
      • Systemic Presentation: Rapid onset of high fever (≥38.9 ∘C\ge 38.9\,^\circ\text{C} / 102.0 ∘F102.0\,^\circ\text{F}) accompanied by chills.
      • Dermatological Manifestations: Diffuse macular erythroderma (sunburn-like rash), conjunctival hyperemia, petechiae, vesicles, bullae, and non-pitting edema; followed by extensive desquamation 1–2 weeks1\text{--}2\,\text{weeks} post-rash onset.
      • Hemodynamic Collapse: Hypotension (Systolic Blood Pressure≤90 mmHg\text{Systolic Blood Pressure} \le 90\,\text{mmHg}), orthostatic changes, or syncope.
      • Multiorgan Dysfunction:
        • Central Nervous System: Encephalopathy characterized by confusion, disorientation, and lethargy.
        • Hepatic Failure: Elevated serum total bilirubin, AST, and ALT enzymes.
        • Renal Failure: Elevated BUN and serum creatinine (prerenal azotemia or intrinsic renal injury).
        • Hematological: Thrombocytopenia, prolonged clotting times, low serum fibrinogen levels, and disseminated intravascular coagulation (DIC).
        • Musculoskeletal: Severe myalgias, muscle proteolysis, and elevated serum creatine phosphokinase (CPK).
        • Gastrointestinal: Severe vomiting or diarrhea.
      • Associated Risk Factors: Use of high-absorbency tampons, intrauterine contraceptive devices (IUD), contraceptive sponges, infected surgical wounds, or retained surgical packing/foreign materials requiring debridement.

Clinical presentation and organ involvement of Staphylococcal Toxic Shock Syndrome

Microbiological Diagnosis of Staphylococcus

  • Specimen Collection (Muestras):

    • Purulent exudates, abscess fluid, wound swabs, blood cultures, sputum, or infected tissues based on the site of involvement.
  • Direct Microscopic Examination (Frotis):

    • Gram staining reveals Gram-positive cocci (0.5–1.5 μm0.5\text{--}1.5\,\mu\text{m}) arranged singly, in pairs, or in characteristic irregular clusters.
  • Culture Techniques (Cultivo):

    • Grows readily on non-selective media (Nutrient Agar, Blood Agar demonstrating β\beta-hemolysis for S. aureus).
    • Mannitol Salt Agar (Agar Manitol Salado): Selective and differential medium containing 7.5%7.5\% NaClNaCl and mannitol; S. aureus ferments mannitol, turning the phenol red indicator yellow.
  • Primary Identification Tests:

    • Catalase Test (Prueba de la Catalasa): Differentiation of catalase-positive Staphylococcus from catalase-negative Streptococcus.
    • Coagulase Test (Prueba de la Coagulasa): Differentiates S. aureus (coagulase-positive) from coagulase-negative staphylococci (CoNS).

Diagnostic methods scheme for Staphylococcus

  • Epidemiological Typing Methods:
    • Antibiotype profiling (Antibiograma).
    • Biotyping and Phagetyping (Fagotipia).
    • Molecular characterization using Pulsed-Field Gel Electrophoresis (PFGE).

Epidemiology, Prevention, and Treatment

  • Epidemiological Characteristics:

    • Asymptomatic Carriage: Approximately 15–30%15\text{--}30\% of healthy human adults are persistent or transient nasopharyngeal carriers of S. aureus.
    • Transmission Routes: Autoinfection, direct person-to-person contact, airborne droplets, and contact with contaminated inanimate objects (fomites).
    • Methicillin-Resistant Staphylococcus aureus (SARM / MRSA): Major hospital-acquired (nosocomial) and community-associated pathogen resistant to standard β\beta-lactam therapies.
  • General Prophylaxis and Hygiene Measures:

    • Rigorous hand hygiene protocols and antiseptic disinfectant application.
    • Laundering contaminated linens and clothing at elevated temperatures.
    • Targeted decolonization of nasal carriers (e.g., intranasal mupirocin).
    • Surgical antimicrobial prophylaxis prior to high-risk operative procedures.
    • Adherence to Good Manufacturing Practices (GMP) in food handling (adequate cooking, refrigeration, strict personnel hygiene, exclusion of workers with unmasked open skin lesions).
  • Control of Methicillin-Resistant S. aureus (SARM / MRSA) Outbreaks:

    • Implementation of active epidemiological surveillance systems.
    • Strict contact isolation of infected or colonized patients.
    • Screening and decolonization of healthcare personnel carriers.
    • Ongoing staff education and infection control training.
  • Antimicrobial Therapy:

    • Antimicrobial susceptibility testing (antibiogram) is required to establish strain susceptibility profiles before finalizing therapy.
    • β\beta-Lactam Antibiotics: Penicillinase-resistant penicillins (e.g., oxacillin, nafcillin) or first-generation cephalosporins (e.g., cefazolin) for susceptible isolates (MSSA).
    • Tetracyclines: Effective option (e.g., doxycycline) for sensitive cutaneous or mild infections.
    • Vancomycin: Glycopeptide of choice for treating Methicillin-Resistant Staphylococcus aureus (SARM / MRSA) or severe systemic infections in patients allergic to β\beta-lactams.

Coagulase-Negative Staphylococci (CoNS)

  • Clinical Significance:

    • Opportunistic pathogens lacking coagulase production.
    • Primarily associated with foreign body medical devices and nosocomial environments due to biofilm production.
  • Staphylococcus epidermidis:

    • Major component of normal skin flora.
    • High propensity to form adherent biofilms on synthetic surfaces.
    • Associated Pathologies:
      • Intravascular catheter-related bloodstream infections.
      • Prosthetic joint and orthopedic implant infections.
      • Prosthetic valve endocarditis.
  • Staphylococcus saprophyticus:

    • Selective pathogen of the female urogenital tract.
    • Second most frequent cause of uncomplicated community-acquired Urinary Tract Infections (UTI / ITU) in young, sexually active females (second only to Escherichia coli).